JUN and ovarian carcinoma: First, we observed that the complex of cJUN and JNK translocated into the nucleus in the cisplatin-resistant ovarian cancer cell lines exposed to cisplatin, suggesting that the JNK-cJUN axis was activated in the cisplatin-treated ovarian cancer cell lines (Figure 6a).